glp-1 wiki Understanding receptor agonists and their impact on drug discovery GLP-1 | Summary

Diabetic retinopathy: This phenomenon occurs when mild or previously undiagnosed diabetic retinopathy an eye disease caused by chronic uncontrolled diabetes suddenly gets worse after starting a GLP-1 RA

N Engl J Med 2008;358:2560-2572

are "compounded" rather than FDA-approved mass-market drugs

In laboratory and pre-clinical settings, AOD9604 has been studied across several distinct biological systems

IGF-1 LR3 Reconstitution Reference (1 mg / 1,000 mcg vial) BAC water added 1 mL Concentration 1,000 mcg/mL 20 mcg dose 0.02 mL (2 units) 40 mcg dose 0.04 mL (4 units) 50 mcg dose 0.05 mL (5 units) 80 mcg dose 0.08 mL (8 units) 100 mcg dose 0.10 mL (10 units) BAC water added 2 mL Concentration 500 mcg/mL 20 mcg dose 0.04 mL (4 units) 40 mcg dose 0.08 mL (8 units) 50 mcg dose 0.10 mL (10 units) 80 mcg dose 0.16 mL (16 units) 100 mcg dose 0.20 mL (20 units) BAC water added 3 mL Concentration 333 mcg/mL 20 mcg dose 0.06 mL (6 units) 40 mcg dose 0.12 mL (12 units) 50 mcg dose 0.15 mL (15 units) 80 mcg dose 0.24 mL (24 units) 100 mcg dose 0.30 mL (30 units) Units refer to U-100 insulin syringe markings